Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
BIOMARKER:
HRAS Q61L + NRAS Q61K
i
Other names:
NRAS1, N-Ras Protein Part 4, Neuroblastoma RAS Viral (V-Ras) Oncogene Homolog, NRAS, Neuroblastoma RAS Viral Oncogene Homolog, NRAS Proto-Oncogene, GTPase, HRAS, HRAS1, Harvey rat sarcoma viral oncogene homolog
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
4893
;
3265
Related biomarkers:
Expression
Mutation
CNA
Others
‹
FGF19 amplification + HRAS Q61R + TP53 672+2T>G (6)
FGF3 amplification + HRAS Q61R + TP53 672+2T>G (6)
FGF4 amplification + HRAS Q61R + TP53 672+2T>G (6)
EGFR exon 19 deletion + NRAS Q61K (3)
PD-L1 expression + NRAS Q61R + BRAF D594N (2)
CDKN2A Negative + NRAS Mutation (1)
Chr t(11;14) + NRAS mutation (1)
KRAS wild-type + NRAS wild-type + MSI-H/dMMR (1)
MLL-AFF1 fusion + NRAS mutation (1)
NRAS mutation + BRAF wild-type (1)
NRAS wild-type + NOTCH4 mutation (1)
HRAS Q61R + TP53 P278S + PD-L1 overexpression (1)
HRAS overexpression + PIK3CA amplification (1)
HRAS overexpression + PIK3CA mutation (1)
FGF19 amplification + HRAS Q61R + TP53 672+2T>G (6)
FGF3 amplification + HRAS Q61R + TP53 672+2T>G (6)
FGF4 amplification + HRAS Q61R + TP53 672+2T>G (6)
EGFR exon 19 deletion + NRAS Q61K (3)
PD-L1 expression + NRAS Q61R + BRAF D594N (2)
CDKN2A Negative + NRAS Mutation (1)
Chr t(11;14) + NRAS mutation (1)
KRAS wild-type + NRAS wild-type + MSI-H/dMMR (1)
MLL-AFF1 fusion + NRAS mutation (1)
NRAS mutation + BRAF wild-type (1)
NRAS wild-type + NOTCH4 mutation (1)
HRAS Q61R + TP53 P278S + PD-L1 overexpression (1)
HRAS overexpression + PIK3CA amplification (1)
HRAS overexpression + PIK3CA mutation (1)
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
HRAS Q61L + NRAS Q61K
Lung Adenocarcinoma
HRAS Q61L + NRAS Q61K
Lung Adenocarcinoma
osimertinib
Resistant: C4 – Case Studies
osimertinib
Resistant
:
C4
osimertinib
Resistant: C4 – Case Studies
osimertinib
Resistant
:
C4
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.